1315. Interactive Panelist
Session: Interactive Session: Hepatitis C in Practice
Saturday, October 22, 2011: 1:45 PM
Room: Grand Ballroom (East-West)


Mark Sulkowski, MD, John Hopkins University School of Medicine, Baltimore, MD

CURRICULUM VITAE
Mark S. Sulkowski, MD

June 29, 2007
DEMOGRAPHIC INFORMATION
Current Appointments
Associate Professor of Medicine
Department of Medicine
Johns Hopkins University School of Medicine
Hospitals
The Johns Hopkins Hospital
The Johns Hopkins Bayview Hospital
Personal Data
1830 Monument Street, Room 448
Baltimore, Maryland 21287
Phone: 410-614-4172
Fax:
410-614-5138
Email:
msulkows@jhmi.edu
DOB:
December 13, 1965
Education and Training
B.S.
1988
Lehigh University, Biology
Bethlehem, Pennsylvania
M.D.
1992
Temple University School of Medicine
Philadelphia, Pennsylvania
Internship
1992-1993
Intern in Medicine
Duke University Medical Center
Durham, North Carolina
Residency
1993-1995
Resident in Medicine
Duke University Medical Center
Durham, North Carolina
Fellowship
1995-1998
Fellow in Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, Maryland
Post-Doctoral
1996
Biostatistics and Epidemiology Advanced Courses
Johns Hopkins University School of Hygiene and Public Health, Baltimore, Maryland
Professional Experiences
1994
Assistant Chief Resident
Duke University Medical Center, Durham, North Carolina
1996-1998
Attending Physician, Infectious Diseases Consult Service
Union Memorial Hospital, Baltimore, Maryland
1998-2004
Assistant Professor of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland
Medical Director, Johns Hopkins University Viral Hepatitis Center, Division of Infectious Diseases
1999-2005
Vice-President, Hepatitis Resource Network, Tacoma, Washington.
1999-2005
Director, Clinical Research. Hepatitis Resource Network, Tacoma, Washington
2001-
Co-investigator, Johns Hopkins University Adult AIDS Clinical Trials Unit
2002-
Member, Adult AIDS Clinical Trials Group, Liver Diseases Sub-committee.
2003-
Member, Johns Hopkins Adult General Clinical Research Center, Protocol Review Committee.
Member, Hepatitis Advisory Group, Adult AIDS Clinical Trials Group
2003-2006
Co-chair, Adult AIDS Clinical Trials Group Protocol A5184: An open-label, randomized, phase III study to determine the impact of antiretroviral treatment of HIV in HCV/HIV coinfected subjects with high CD4 on the efficacy of hepatitis C treatment with pegylated interferon and ribavirin.
2004-
Associate Professor of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland
2008 -
Member, Clinical Research Committee, American Association for the Study of Liver Disease
2008 -
Joint appointment, Division of Gastroenterology/Hepatology, Johns Hopkins University School of Medicine, Baltimore Maryland



See more of: Hepatitis C in Practice
See more of: Interactive Session
Previous Presentation | Next Presentation >>

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.